Does EVOLOCUMAB Cause Diabetes mellitus? 538 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 538 reports of Diabetes mellitus have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
538
Reports of Diabetes mellitus with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
17
Deaths
44
Hospitalizations
How Dangerous Is Diabetes mellitus From EVOLOCUMAB?
Of the 538 reports, 17 (3.2%) resulted in death, 44 (8.2%) required hospitalization, and 4 (0.7%) were considered life-threatening.
Is Diabetes mellitus Listed in the Official Label?
Yes, Diabetes mellitus is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Diabetes mellitus?
ADALIMUMAB (2,763)
ETANERCEPT (2,045)
PREDNISONE (1,832)
METHOTREXATE (1,547)
METFORMIN (1,377)
SACUBITRIL\VALSARTAN (1,214)
RITUXIMAB (1,051)
OLANZAPINE (989)
ABATACEPT (953)
ALBUTEROL (950)
Which EVOLOCUMAB Alternatives Have Lower Diabetes mellitus Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE